SCHEMBL20274848

SCHEMBL20274848

C=C(NC1CCCC1)c1csc(C)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 11/20 0.56
▸ NPC1 O15118 9/20 0.56
▸ DAO P14920 1/20 0.41
▸ ALDH1A1 P00352 4/20 0.40
▸ HPGD P15428 4/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ KMT2A Q03164 3/20 0.38
▸ GAA P10253 1/20 0.38
▸ SMN1; SMN2 Q16637 4/20 0.38
▸ TP53 P04637 2/20 0.38
▸ CYP1A2 P05177 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ TAS1R3 Q7RTX0 2/20 0.36
▸ TAS1R1 Q7RTX1 2/20 0.36
▸ TAS1R2 Q8TE23 2/20 0.36
▸ HTT P42858 1/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ HSD17B10 Q99714 2/20 0.36
▸ USP2 O75604 1/20 0.36
▸ POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12124461 0.81 RAB9A (0.71) RAB9ANPC1DAOALDH1A1HPGD
SCHEMBL12124462 0.79 RAB9A (0.73) RAB9ANPC1ALDH1A1HPGDKMT2A
SCHEMBL12124368 0.77 RAB9A (0.67) RAB9ANPC1DAOALDH1A1HPGD
SCHEMBL20925996 0.75 HTT (0.44) RAB9ANPC1ALDH1A1HPGDKMT2A
SCHEMBL12124434 0.73 NPC1 (0.62) RAB9ANPC1DAOALDH1A1HPGD
SCHEMBL22279371 0.71 NPC1 (0.66) RAB9ANPC1HPGDKMT2ASMN1; SMN2
SCHEMBL22055783 0.69 NPC1 (0.44) RAB9ANPC1ALDH1A1HPGDSMN1; SMN2
SCHEMBL22877114 0.68 RAB9A (0.53) RAB9ANPC1ALDH1A1HPGDKMT2A
SCHEMBL12124244 0.68 KDM1A (0.56) RAB9ANPC1DAOALDH1A1HPGD
SCHEMBL12124258 0.68 NPC1 (0.55) RAB9ANPC1DAOALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3336090-B1 IRAK4 INHIBITOR AND USE THEREOF BEIJING HANMI PHARMACEUTICAL CO LTD (CN) 2020-07-22 — — EP disclosed
EP-3336090-A1 IRAK4 INHIBITOR AND USE THEREOF Beijing Hanmi Pharmaceutical Co., Ltd. (CN) 2018-06-20 — — EP disclosed
Send feedback